We are live on ! Find out more
HCAT icon

Health Catalyst

1.70 USD
-0.03
1.73%
At close Updated Sep 11, 4:00 PM EDT
Pre-market
After hours
1.70
0.00
0%
1 day
-1.73%
5 days
1.19%
1 month
-3.41%
3 months
3.66%
6 months
-8.6%
Year to date
-25.44%
1 year
-47.53%
5 years
-96.89%
10 years
-95.66%
 

About: Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Employees: 1,200

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 36.4%
Neutral 63.6%
Negative 0%
Neutral
GlobeNewsWire
4 days ago
Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President
SALT LAKE CITY, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst” or the “Company,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that Simeon Kohl has been appointed Chief Executive Officer (CEO) and President and a member of the Company's Board of Directors, effective September 14, 2026.
Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President
Neutral
GlobeNewsWire
11 days ago
Health Catalyst to Participate in Upcoming Investor Conference
SALT LAKE CITY, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced that members of senior management will participate in the 2026 Wells Fargo Healthcare Conference, taking place in Boston, on Wednesday, September 9, 2026 and Thursday, September 10, 2026.
Health Catalyst to Participate in Upcoming Investor Conference
Positive
MarketBeat
1 month ago
Health Catalyst Q2 Earnings Call Highlights
Health Catalyst NASDAQ: HCAT reported second-quarter 2026 revenue above the high end of its guidance range and adjusted EBITDA at the high end of its outlook, while outlining a strategic shift following the July 31 divestiture of its Vitalware and Med-Metrix businesses.
Health Catalyst Q2 Earnings Call Highlights
Neutral
Seeking Alpha
1 month ago
Health Catalyst, Inc. (HCAT) Q2 2026 Earnings Call Transcript
Health Catalyst, Inc. (HCAT) Q2 2026 Earnings Call Transcript
Health Catalyst, Inc. (HCAT) Q2 2026 Earnings Call Transcript
Positive
Zacks Investment Research
1 month ago
Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Health Catalyst (HCAT) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics
Positive
Zacks Investment Research
1 month ago
Health Catalyst (HCAT) Beats Q2 Earnings and Revenue Estimates
Health Catalyst (HCAT) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.04 per share a year ago.
Health Catalyst (HCAT) Beats Q2 Earnings and Revenue Estimates
Neutral
PRNewsWire
1 month ago
Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company
Company retires all credit facility debt; transaction reflects concentrating its technology on improving health system performance. SALT LAKE CITY, Aug. 6, 2026 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst" or the "Company," Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today announced it closed the sale of Vitalware, LLC, through which the Company conducted its Vitalware business, to Med-Metrix, LLC, a technology-enabled revenue cycle management company, on July 31, 2026.
Health Catalyst Completes Sale of Vitalware, Sharpening Its Focus as a Healthcare Intelligence Company
Neutral
GlobeNewsWire
1 month ago
Health Catalyst Reports Second Quarter 2026 Results
SALT LAKE CITY, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, today reported financial results for the quarter ended June 30, 2026. “We delivered a very productive second quarter, exceeding the high end of our revenue guidance and the midpoint of our adjusted EBITDA guidance," said Ben Albert, Chief Executive Officer of Health Catalyst.
Health Catalyst Reports Second Quarter 2026 Results
Neutral
GlobeNewsWire
1 month ago
Health Catalyst to Announce Second Quarter 2026 Operating Results and Host Conference Call on Thursday, August 6, 2026
SALT LAKE CITY, July 28, 2026 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst”, Nasdaq: HCAT), a healthcare intelligence company designed to accelerate measurable improvement for health systems, will release its second quarter 2026 operating results on Thursday, August 6, 2026, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day.
Health Catalyst to Announce Second Quarter 2026 Operating Results and Host Conference Call on Thursday, August 6, 2026
Positive
MarketBeat
1 month ago
Health Catalyst Investors Approve Directors, Pay; Board Declassification Fails
Health Catalyst NASDAQ: HCAT stockholders approved three of four proposals presented at the company's 2026 annual meeting, including the election of two directors, ratification of the company's auditor and an advisory vote on executive compensation. A proposal to phase out the company's classified board structure did not receive the required level of support.
Health Catalyst Investors Approve Directors, Pay; Board Declassification Fails
Price charts implemented using Lightweight Charts™